Shenzhen Salubris Pharmaceuticals (SHE:002294) posted third-quarter attributable net profit of 215.6 million yuan, up 31% from the previous year.
Earnings per share rose 27% to 0.19 yuan, according to a Tuesday filing with the Shanghai bourse.
Operating revenue climbed 16% year over year to 1.11 billion yuan.
Shares of the pharmaceutical company climbed 1% Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments